LivaNova (LIVN) Return on Capital Employed Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 362.00 |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 1,517.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,517.00 |
| Dec 31, 2025 | 1,516.00 |
| Sep 30, 2025 | 1,469.00 |
| Jun 30, 2025 | 638.00 |
| Mar 31, 2025 | 829.00 |
| Dec 31, 2024 | 613.00 |
| Sep 30, 2024 | 1,702.00 |
| Jun 30, 2024 | 1,576.00 |
| Mar 31, 2024 | 1,100.00 |
| Dec 31, 2023 | 938.00 |
| Sep 30, 2023 | 921.00 |
| Jun 30, 2023 | 106.00 |
| Mar 31, 2023 | 333.00 |
| Dec 31, 2022 | 474.00 |
| Sep 30, 2022 | 1,105.00 |
| Jun 30, 2022 | 2,042.00 |
| Mar 31, 2022 | 1,513.00 |
| Dec 31, 2021 | 1,185.00 |
| Sep 30, 2021 | -1,882.00 |
| Jun 30, 2021 | -2,140.00 |
| Mar 31, 2021 | -1,752.00 |
| Dec 31, 2020 | -1,722.00 |
| Sep 30, 2020 | -1,040.00 |
| Jun 30, 2020 | -912.00 |
| Mar 31, 2020 | -1,078.00 |
| Dec 31, 2019 | -1,019.00 |
| Sep 30, 2019 | -1,528.00 |
| Jun 30, 2019 | -1,701.00 |
| Mar 31, 2019 | -1,453.00 |